ACTIVE

DOKTER DEMUYNCK ENDOCRINO - DIABETOLOGIE

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result134,8 k €+3,0 %over 1 year
Gross margin204,4 k €+3,7 %over 1 year
Equity370 k €+0,8 %over 1 year

Identity

Source · BCE/KBO

DOKTER DEMUYNCK ENDOCRINO - DIABETOLOGIE is a Private limited company incorporated in 2011. Its main activity is: Specialist medical practice activities. Its registered office is in Boechout.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0836.577.389
Incorporation
11/05/2011
Legal form
Private limited company
Registered office
Guido Gezellestraat 20
2530 Boechout · FlandreSee on map
Contributed capital
12 400,00 €
Latest accounts
31/12/2025
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 14 filings

Trend over 14 financial years

20252024202320222021
Income statement
Gross margin204,4 k €197,1 k €177 k €172,9 k €149,5 k €
EBITDA203,5 k €195,1 k €176,3 k €171 k €148,9 k €
Operating result190,2 k €182,9 k €157,2 k €152,3 k €129 k €
Net result134,8 k €130,9 k €114,1 k €110,1 k €93,4 k €
Balance sheet
Equity370 k €367 k €272,3 k €231,6 k €212,9 k €
Total assets498,7 k €555,7 k €487,8 k €422,6 k €414 k €
Cash181,4 k €111 k €45,2 k €128,3 k €78,2 k €
Debts128,7 k €188,7 k €215,5 k €191 k €201 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Sandra Demuynck
DirectorAdministrator - managerendedManagerended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date03/07/202605/09/202531/07/202422/08/202320/06/202227/10/2021
General meeting11/05/202612/05/202513/05/202408/05/202309/05/202210/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 14 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202511/05/202603/07/2026DutchPDF
Micro model31/12/202412/05/202505/09/2025DutchPDF
Micro model31/12/202313/05/202431/07/2024DutchPDF
Micro model31/12/202208/05/202322/08/2023DutchPDF
Micro model31/12/202109/05/202220/06/2022DutchPDF
Micro model31/12/202010/05/202127/10/2021DutchPDF
Micro model31/12/201920/07/202029/09/2020DutchPDF
Micro model31/12/201813/05/201930/07/2019DutchPDF
Micro model31/12/201714/05/201820/09/2018DutchPDF
Micro model31/12/201608/05/201728/09/2017DutchPDF
Abridged model31/12/201509/05/201630/08/2016DutchPDF
Abridged model31/12/201411/05/201508/07/2015DutchPDF
Abridged model31/12/201312/05/201422/08/2014DutchPDF
Abridged model31/12/201213/05/201325/06/2013DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Sandra Demuynck
DirectorAdministrator - managerendedManagerended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates30/01/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other08/06/2011
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
20122014201620182020202220242026
Identity
Incorporation
Name
DOKTER DEMUYNCK ENDOCRINO - DIABETOLOGIE
Registered office
Guido Gezellestraat 20, 2530 Boechout
Annual accounts
Filings14 filings
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Guido Gezellestraat 20, 2530 BoechoutCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00250393

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
DOKTER DEMUYNCK ENDOCRINO - DIABETOLOGIECurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00250393

Events

  1. 2025
    Annual accounts 2025134,8 k €↑
  2. 2024
    Annual accounts 2024130,9 k €↑
  3. 2023
    Annual accounts 2023114,1 k €↑
  4. 2022
    Annual accounts 2022110,1 k €↑
  5. 2021
    Annual accounts 202193,4 k €↑
  6. 2020
    Annual accounts 202072,4 k €↑
  7. 2019
    Annual accounts 201936,2 k €↓
  8. 2018
    Annual accounts 201849,4 k €↓
  9. 2017
    Annual accounts 201760,3 k €↓
  10. 2016
    Annual accounts 201671,5 k €↑
  11. 2015
    Annual accounts 201547,2 k €↓
  12. 2014
    Annual accounts 201460 k €↑
  13. 2013
    Annual accounts 201317,8 k €↓
  14. 2012
    Annual accounts 201221,4 k €
  15. 11/05/2011
    IncorporationPrivate limited company